Thank you. Dianna S.
A further dimension emerged in May 2026, when the ATTAIN-MAINTAIN trial, published in Nature Medicine , found that patients who switched to orforglipron after achieving substantial weight loss on injectable GLP-1s maintained approximately 7580% of that weight reduction
While this supports calorie reduction, it can also increase the risk of: Inadequate protein intake Loss of lean muscle mass alongside fat loss Constipation and digestive discomfort Skipped or inconsistent meals Structured, nutritionally balanced eating helps maximize results while minimizing side effects
Real-world comparison of steatosis-associated fibrosis estimator and fibrosis-4 scores for assessing metabolic dysfunction-associated steatotic liver disease-related fibrosis in a highly diverse urban metabolic dysfunction-associated steatotic liver disease population
Lilly said that with insurance, the cost will start at a $25 per month with a Lilly discount card
Recent studies have raised concerns about a potential link between Ozempic (semaglutide) and serious vision problems, particularly the rare condition known as non-arteritic anterior ischemic optic neuropathy (NAION)